Patent details

Basic Information

Publication number:

EP3135668

PCT Application Number:

JP2015062440

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157824582

PCT Publication Number:

WO2015163427

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND

French Title of Invention:

NOUVEAU COMPOSÉ 1,2,4-TRIAZINE DISUBSTITUÉ

German Title of Invention:

NEUARTIGE DISUBSTITUIERTE 1,2,4-TRIAZIN-VERBINDUNG

SPC Number:

Dates

Filing date:

23/04/2015

Grant date:

18/12/2019

EP Publication Date:

01/03/2017

PCT Publication Date:

29/10/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/12/2019

EP B1 Publication Date:

18/12/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/04/2020

Expiration date:

23/04/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/12/2019

 

 

Name:

Mitsubishi Tanabe Pharma Corporation

Address:

3-2-10, Dosho-machi, Chuo-ku, Osaka-shi,, Osaka 541-8505, Japan (JP)

Inventor

1

Name:

USHIROGOCHI, Hideki

Address:

Japan (JP)

2

Name:

ONDA, Yuichi

Address:

Japan (JP)

3

Name:

SAKAKIBARA, Ryo

Address:

Japan (JP)

4

Name:

SASAKI, Wataru

Address:

Japan (JP)

5

Name:

AKAHOSHI, Fumihiko

Address:

Japan (JP)

Priority

Priority Number:

2014090754

Priority Date:

24/04/2014

Priority Country:

Japan (JP)

Classification

IPC classification:

A61P 9/04; A61P 13/12; C07D 253/07; C07D 451/02;

Publication

European Patent Bulletin

Issue number:

201951

Publication date:

18/12/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages